Skip to main content

pJEP300-pAAV-CMV-MCS2-pA Citations (1)

Originally described in: The Development of an AAV-Based CRISPR SaCas9 Genome Editing System That Can Be Delivered to Neurons in vivo and Regulated via Doxycycline and Cre-Recombinase.
Kumar N, Stanford W, de Solis C, Aradhana, Abraham ND, Dao TJ, Thaseen S, Sairavi A, Gonzalez CU, Ploski JE Front Mol Neurosci. 2018 Nov 13;11:413. doi: 10.3389/fnmol.2018.00413. eCollection 2018.
PubMed Journal

Articles Citing pJEP300-pAAV-CMV-MCS2-pA

Articles
Directly reprogrammed NK cells driven by BCL11B depletion enhance targeted immunotherapy against pancreatic ductal adenocarcinoma. Kim HS, Kim JY, Lee JY, Seol B, Choi JE, Cho YS. J Hematol Oncol. 2025 Nov 13;18(1):100. doi: 10.1186/s13045-025-01730-1. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.